These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6806086)

  • 1. Diurnal oscillations in plasma protein binding of valproic acid.
    Patel IH; Venkataramanan R; Levy RH; Viswanathan CT; Ojemann LM
    Epilepsia; 1982 Jun; 23(3):283-90. PubMed ID: 6806086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-dependent interaction between phenytoin and valproic acid.
    Riva R; Albani F; Contin M; Perucca E; Ambrosetto G; Gobbi G; Santucci M; Procaccianti G; Baruzzi A
    Neurology; 1985 Apr; 35(4):510-5. PubMed ID: 3920548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic interaction between valproic acid and free fatty acids in rhesus monkeys.
    Johno I; Huang MY; Levy RH
    Epilepsia; 1982 Dec; 23(6):649-56. PubMed ID: 6816579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum protein binding of phenytoin and valproic acid in insulin-dependent diabetes mellitus.
    Gatti G; Crema F; Attardo-Parrinello G; Fratino P; Aguzzi F; Perucca E
    Ther Drug Monit; 1987 Dec; 9(4):389-91. PubMed ID: 3122377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related changes in valproic acid binding to rat serum proteins in vitro.
    Slattum PW; Cato AE; Pollack GM; Brouwer KL
    J Pharm Sci; 1996 Apr; 85(4):373-6. PubMed ID: 8901071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenytoin--valproic acid interaction in rhesus monkey.
    Koch KM; Ludwick BT; Levy RH
    Epilepsia; 1981 Feb; 22(1):19-25. PubMed ID: 6781887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of unbound valproic acid concentration in plasma by equilibrium dialysis and gas--liquid chromatography: methodological aspects and observations in epileptic patients.
    Riva R; Albani F; Baruzzi A; Galvani I; Perucca E
    Ther Drug Monit; 1982; 4(4):341-52. PubMed ID: 6818733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of altered drug binding to serum proteins in pregnant women: studies with valproic acid.
    Riva R; Albani F; Contin M; Baruzzi A; Altomare M; Merlini GP; Perucca E
    Ther Drug Monit; 1984; 6(1):25-30. PubMed ID: 6424276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonlinear binding of valproic acid (VPA) and E-delta 2-valproic acid to rat plasma proteins.
    Semmes RL; Shen DD
    Pharm Res; 1990 May; 7(5):461-7. PubMed ID: 2114617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender- or age-related binding characteristics of valproic acid to serum proteins in adult patients with epilepsy.
    Kodama Y; Kodama H; Kuranari M; Tsutsumi K; Ono S; Yukawa E; Fujimura A
    Eur J Pharm Biopharm; 2001 Jul; 52(1):57-63. PubMed ID: 11438424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic acid binding to human serum albumin and determination of free fraction in the presence of anticonvulsants and free fatty acids.
    Patel IH; Levy RH
    Epilepsia; 1979 Feb; 20(1):85-90. PubMed ID: 369855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid: in vitro plasma protein binding and interaction with phenytoin.
    Cramer JA; Mattson RH
    Ther Drug Monit; 1979; 1(1):105-16. PubMed ID: 121944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A clinicopharmacological study of serum sodium valproate free level in children with epilepsy].
    Furuya M; Hashimoto K; Kamayachi S; Fujino O
    Nihon Ika Daigaku Zasshi; 1990 Dec; 57(6):513-23. PubMed ID: 2286644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein binding of valproic acid in the presence of elevated free fatty acids in patient and normal human serum.
    Zimmerman CL; Patel IH; Levy RH; Edwards D; Nelson SD; Hutchinson M
    Epilepsia; 1981 Feb; 22(1):11-7. PubMed ID: 6781885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma protein-binding and CSF concentrations of valproic acid in man following acute oral dosing.
    Rapeport WG; Mendelow AD; French G; MacPherson P; Teasdale E; Agnew E; Thompson GG; Brodie MJ
    Br J Clin Pharmacol; 1983 Oct; 16(4):365-9. PubMed ID: 6414500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free fraction of valproic acid: in vitro time-dependent increase and correlation with free fatty acid concentration in human plasma and serum.
    Albani F; Riva R; Procaccianti G; Baruzzi A; Perucca E
    Epilepsia; 1983 Feb; 24(1):65-73. PubMed ID: 6401631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum protein binding of valproic acid in healthy subjects and in patients with liver disease.
    Urien S; Albengres E; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):319-25. PubMed ID: 6790449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated free fatty acid concentrations in lipemic sera reduce protein binding of valproic acid significantly more than phenytoin.
    Dasgupta A; Crossey MJ
    Am J Med Sci; 1997 Feb; 313(2):75-9. PubMed ID: 9030671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of serum protein binding in epileptic children during sodium valproate maintenance therapy.
    Yu HY
    Ther Drug Monit; 1984; 6(4):414-23. PubMed ID: 6440321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring free valproic acid in epilepsy patients medicated with coanticonvulsants.
    Haidukewych D; Rodin EA
    Ther Drug Monit; 1982; 4(2):209-12. PubMed ID: 6808716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.